To evaluate whether co-targeting of JNK and HUNK had an added effect on breast cancer cell death of JIMT-1 cells we next treated control and HUNK knockdown cells with JNK inhibitor and evaluated the cells for Caspase-3 activity. The gene discussed is CASP3; the disease is breast carcinoma.